MyZA

News, Directory, Events and Other Stuff

You are here: Home / News / MyPR / Cipla Medpro South Africa (Pty) Ltd (“Cipla South Africa”) to acquire Actor Pharma (Pty) Ltd

Cipla Medpro South Africa (Pty) Ltd (“Cipla South Africa”) to acquire Actor Pharma (Pty) Ltd

Cipla Medpro South Africa (Pty) Ltd (“Cipla South Africa”) to acquire Actor Pharma (Pty) Ltd. Strengthens its over-the-counter product portfolio South Africa, 5 September 2023 Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as “Cipla”) signed a binding term sheet with Actor Holdings (Pty) Limited …

  • Cipla Medpro South Africa (Pty) Ltd (“Cipla South Africa”) to acquire Actor Pharma (Pty) Ltd.
  • Strengthens its over-the-counter product portfolio

South Africa, 5 September 2023 Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as “Cipla”) signed a binding term sheet with Actor Holdings (Pty) Limited to acquire 100% of the issued ordinary shares of Actor Pharma (Pty) Limited (“Actor”). This development underpins Cipla’s commitment and investment in its over the counter (OTC) business and supports its journey to be a leading healthcare player in South Africa. This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities and leverage cost synergies in the South African market.

Actor was founded in 2009 and has quickly grown to become the 5th largest, privately owned, OTC player in the South African private market. Actor specialises in OTC and generic medicine, where they maintain established strong consumer brands, and identified niche prescription markets in categories of Women’s health, Nasal, Cough & Cold and Baby & Child. In addition, Actor has an exciting and innovative pipeline and in its last financial year (FY23) delivered revenue of R234 million, on the back of strong double-digit growth.

Commenting on the acquisition, Umang Vohra, Global MD & CEO, Cipla Limited said, “This is in line with our strategy of strengthening our OTC and wellness portfolio. We believe this is an excellent opportunity to leverage our existing marketing capabilities, unlock future growth opportunities and optimise the performance of our pipeline”.

Paul Miller, CEO, Cipla South Africa said, “This is a unique opportunity that helps to build Cipla’s OTC portfolio, providing the business with a more balanced revenue contribution between the prescription and over-the-counter business and continue to provide additional quality medicines for consumers”.

Lynton Lomas, shareholder of Actor said, “We are delighted to transact with a company of Cipla’s stature. With the focussed approach of their commercial team, we are excited to see Actor grow from strength to strength in future”.

The transaction is expected to close in the next three to four months, subject to the negotiation and signing of the definitive transaction agreements (which are expected to be concluded imminently) as well as receiving regulatory approval from South Africa’s Competition Commission.

About Cipla South Africa

Cipla Medpro South Africa (Pty) Limited (‘Cipla South Africa’) is a wholly owned subsidiary of Cipla Limited, India (‘Cipla’) and 3rd largest pharmaceutical company in South Africa (and 2nd largest in the Rx sector). Through Cipla’s ethos of ‘Caring for Life’, Cipla South Africa produces world-class medicines at affordable prices for the public and private sectors, advancing healthcare for all South Africans.

For more information, visit www.cipla.co.za

CLICK HERE to submit your press release to MyPR.co.za for free.

Read More at the Source

Category: Tag: , , , , , , ,

If you feel strongly about this article then feel free to send MyZA a ‘Letter to the Editor’ using the submission form below:

Letter to the Editor

This field is for validation purposes and should be left unchanged.
If this is in response to an article please include that article title here or as the lead in for the first paragraph of your Letter below.

Separate tags with commas

Localise your letter by naming the city your words are about. Add relevant words describing your subject. Single comma separated words of no more than 5
Your Name(Required)
Your Name will be linked to the website below.
Your personal, business or social media web site
Choose NO to not set up a user account on MyZA. User Accounts will allow you to submit letters under your own Author Name

3 Latest Letters to the Editor:

  • Fun South African fact

    Dear Editor Fun South African fact: towns like Franschhoek and Stellenbosch are home to world-class wine farms set in stunning, scenic surroundings. Regards Aressa Smith In Response to/From: Luxury Properties Seized in New Lottery Crackdown

  • Condolences on the Passing of Lusanda Dumke

    Statement by Leander Kruger MPL – DA Buffalo City Constituency Leader: The Democratic Alliance in Buffalo City Metropolitan Municipality mourns the passing of Springbok Women’s rugby player and Mdantsane trailblazer, Lusanda Dumke, who lost her battle with cancer at the age of 28. South Africa has lost an exceptional athlete, a leader, and a source…

  • Rape Kits Delivered, But…

    Statement by Nicholas Gotsell MP – DA NCOP Member on Security & Justice: The DA can confirm that 2 840 rape kits arrived in Cape Town on Monday, following sustained DA oversight and pressure after multiple police stations across the Western Cape were found to be without this critical forensic evidence tool. While this delivery…

Reader Interactions

Comments

  1. Joan Jett didn\’t give a damn about her reputation, but unless you\’re a teenage rock star, you should probably give a damn about yours.

  2. Many consumers (80%) expect brands and corporations with a social media presence to interact with their customers in meaningful ways.

  3. Myth: PR success is based totally on chance. Fact: While there’s an element of unpredictability to PR, success is really based on strategy. Another common take on PR is that not much planning goes into it – that PR pros just push press releases or spray their message indiscriminately to the media, hoping for an easy hit. This couldn’t be further from the truth. PR is all about timing and strategy. Most successful PR professionals are news junkies, which is helpful because a huge and essential par of the job is staying up-to-date on current events, trends, and breaking news. If anything relevant to your client is going on in the media, you need to act quickly and approach clients with a plan of action for leveraging the opportunity before someone else beats you to the punch. While it may look like certain articles or announcements get published just because the topic is inherently interesting, PR teams work hard on behalf of their clients to cultivate relationships with reporters and prove that certain stories are relevant and worth printing.